CSBR
CHAMPIONS ONCOLOGY, INC.Company Information
- Company Name
- CHAMPIONS ONCOLOGY, INC.
- CIK
- CIK0000771856
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- CSBR: Nasdaq
- Fiscal Year End
- April 30
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- CSBR
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-01-12
- Last sale
- —
- Shares purchased (TTM)
- 87,886
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 5,856,509
- Shares outstanding
- 13,897,535
- Ownership
- 42.14%
Earnings Market Reaction
- Filing date
- 2026-09-11
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash | - | 5 | - | - | - | 10 | - | - | - | 3 | - | - | ||||||
| Cash And Cash Equivalents At Carrying Value | 4 | - | 7 | 9 | 10 | - | 3 | 3 | 3 | - | 4 | 6 | ||||||
| Accounts Receivable Net Current | 14 | 13 | 12 | 12 | 9 | 11 | 16 | 10 | 9 | 10 | 8 | 8 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets Current | 19 | 19 | 20 | 21 | 21 | 22 | 20 | 14 | 13 | 14 | 13 | 14 | ||||||
| Operating Lease Right Of Use Asset | 10 | 4 | 4 | 4 | 5 | 5 | 5 | 6 | 6 | 6 | 7 | 7 | ||||||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | - | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 6 | 7 | 7 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 33 | 27 | 28 | 30 | 31 | 32 | 31 | 25 | 25 | 26 | 27 | 28 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 6 | 7 | 6 | 6 | 5 | 4 | 5 | 5 | 5 | 6 | 5 | 5 | ||||||
| Accrued Liabilities Current | 3 | 3 | 3 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Operating Lease Liability Current | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Other Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Contract With Customer Liability Current | 10 | 9 | 10 | 12 | 14 | 15 | 11 | 10 | 10 | 12 | 13 | 13 | ||||||
| Liabilities Current | 19 | 20 | 21 | 22 | 23 | 24 | 20 | 19 | 19 | 22 | 22 | 21 | ||||||
| Operating Lease Liability Noncurrent | 10 | 3 | 3 | 4 | 4 | 5 | 5 | 5 | 6 | 6 | 6 | 7 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 29 | 23 | 24 | 26 | 27 | 29 | 25 | 25 | 25 | 28 | 29 | 28 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Treasury Stock Common Value | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | ||||||
| Additional Paid In Capital Common Stock | 86 | 86 | 85 | 85 | 85 | 84 | 84 | 84 | 84 | 83 | 83 | 83 | ||||||
| Retained Earnings Accumulated Deficit | -81 | -81 | -80 | -80 | -80 | -80 | -78 | -83 | -83 | -85 | -84 | -82 | ||||||
| Stockholders Equity | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 1 | -0 | -2 | -2 | 0 | ||||||
| Minority Interest | 1 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | ||||||
| Liabilities And Stockholders Equity | 33 | 27 | 28 | 30 | 31 | 32 | 31 | 25 | 25 | 26 | 27 | 28 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Common Stock Shares Issued | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | ||||||
| Shares Outstanding | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCHAMPIONS ONCOLOGY, INC. (CSBR) — SEC Financial Statements & Analysis
CHAMPIONS ONCOLOGY, INC. (CSBR) is a biological products, (no diagnostic substances) company, incorporated in DE. CHAMPIONS ONCOLOGY, INC. trades on Nasdaq as: CSBR. CHAMPIONS ONCOLOGY, INC. (CSBR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-07-31, filed with the SEC on 2026-09-11. Based on that filing, CHAMPIONS ONCOLOGY, INC. carries a market cap of $74.49M, a P/E ratio of -65.63x, a P/B ratio of 16.70x, a P/S ratio of 1.23x, an enterprise value of $70.13M, and an EV/EBITDA multiple of 225.51x. On profitability, it posts a gross margin of 49.82%, an operating margin of -1.68%, a net margin of -1.87%, a Return on Equity (ROE) of -28.49%, a Return on Assets (ROA) of -3.56%, and a Return on Invested Capital (ROIC) of -54.85%. Per share, it reports EPS of $-0.08, diluted EPS of $-0.08, free cash flow per share of $-0.44, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 6.65% year-over-year, net income growth of -138.84% year-over-year, and EPS growth of -138.54% year-over-year. On the balance sheet, it maintains a current ratio of 1.03x, a quick ratio of 0.96x, working capital of $563.00K, a debt-to-equity ratio of 6.46x, a debt ratio of 0.87, free cash flow of $-6.14M (TTM), and net debt of $-4.36M. Figures sourced from SEC EDGAR.
- Market Cap
- $74.49M
- P/E TTM
- -65.63x
- EPS TTM
- $-0.08
- P/B TTM
- 16.70x
- ROE TTM
- -28.49%
- ROA TTM
- -3.56%
- Debt To Equity
- 6.46x
- Free Cash Flow TTM
- $-6.14M
- Net Revenue TTM Growth 1Y
- 6.65%
Data as of 2026-07-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CHAMPIONS ONCOLOGY, INC. in?
CHAMPIONS ONCOLOGY, INC. (CSBR) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does CSBR trade on?
CHAMPIONS ONCOLOGY, INC. (CSBR) trades on the Nasdaq.
Where is CHAMPIONS ONCOLOGY, INC. incorporated?
CHAMPIONS ONCOLOGY, INC. is incorporated in DE.
When was CHAMPIONS ONCOLOGY, INC. (CSBR)'s most recent SEC filing?
CHAMPIONS ONCOLOGY, INC. (CSBR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-07-31, filed with the SEC on 2026-09-11.
What is CSBR's market cap?
CHAMPIONS ONCOLOGY, INC. (CSBR) has a market capitalization of $74.49M as of 2026-07-31.
What is CSBR's EPS (earnings per share)?
CHAMPIONS ONCOLOGY, INC. (CSBR)'s trailing twelve month EPS is $-0.08 as of 2026-07-31.
What is CSBR's ROE (return on equity)?
CHAMPIONS ONCOLOGY, INC. (CSBR)'s trailing twelve month Return on Equity (ROE) is -28.49% as of 2026-07-31.
What is CSBR's ROA (return on assets)?
CHAMPIONS ONCOLOGY, INC. (CSBR)'s trailing twelve month Return on Assets (ROA) is -3.56% as of 2026-07-31.
What is CSBR's ROIC (return on invested capital)?
CHAMPIONS ONCOLOGY, INC. (CSBR)'s trailing twelve month Return on Invested Capital (ROIC) is -54.85% as of 2026-04-30.
What is CSBR's EV/EBITDA?
CHAMPIONS ONCOLOGY, INC. (CSBR)'s trailing twelve month EV/EBITDA is 225.51x as of 2026-07-31.